Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 41-50 of 54 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1995Longitudinal evaluation of serum trypsinogen measurement in pancreatic-insufficient and pancreatic-sufficient patients with cystic fibrosisCouper, R.; Corey, M.; Durie, P.; Forstner, G.; Moore, D.
1999Functional lymphocyte immunophenotypes observed in thalassaemia and haemophilia patients receiving current blood product preparationsHodge, G.; Lloyd, J.; Hodge, S.; Story, C.; Han, P.
2005Enzyme replacement therapy for Gaucher disease in AustraliaGoldblatt, J.; Szer, J.; Fletcher, J.; McGill, J.; Rowell, J.; Wilson, M.
2005The Hunter-McAlpine syndrome results from duplication 5q35-qterHunter, A.; DuPont, B.; McLaughlin, M.; Hinton, L.; Baker, E.; Ades, L.; Haan, E.; Schwartz, C.
2012Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): A new autosomal dominant syndromeWorthley, D.; Phillips, K.; Wayte, N.; Schrader, K.; Healey, S.; Kaurah, P.; Shulkes, A.; Grimpen, F.; Clouston, A.; Moore, D.; Cullen, D.; Ormonde, D.; Mounkley, D.; Wen, X.; Lindor, N.; Carniero, F.; Huntsman, D.; Chenevix-Trench, G.; Suthers, G.
2007Unravelling the molecular control of calvarial suture fusion in children with craniosynostosisCoussens, A.; Wilkinson, C.; Hughes, I.; Morris, C.; Van Daal, A.; Anderson, P.; Powell, B.
2009SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotypeSpurlock, G.; Bennett, E.; Chuzhanova, N.; Thomas, N.; H-Ping, J.; Side, L.; Davies, S.; Haan, E.; Kerr, B.; Huson, S.; Upadhyaya, M.
2000Childhood cancer: A 4-year prospective study of the psychological adjustment of children and parentsSawyer, M.; Antoniou, G.; Toogood, I.; Rice, M.; Baghurst, P.
2005Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human n-acetylgalactosamine 4-sulfataseHarmatz, P.; Ketteridge, D.; Giugliani, R.; Guffon, N.; Teles, E.; Miranda, C.; Yu, Z.; Swiedler, S.; Hopwood, J.
2004Pancreatic β-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetesHarrison, L.; Honeyman, B.; Steele, C.; Stone, N.; Sarugeri, E.; Bonifacio, E.; Couper, J.; Coleman, P.